-
I am tremendously excited by the potential synergies between digital health and medical product development; capturing this value, however, will require a sophisticated understanding -- not only of the technologies, but also of the specific functional needs and tacit local politics of the organization...
Posted to
News
by
Health. Care.
on
Fri, Jan 25 2013
Filed under:
Filed under: health, Pharma & Healthcare, Innovation & Science, byline=David Shaywitz, Strategy, Data Driven, digital health, ticker=NYSE:NVS, biopharmaceutical, ticker=NYSE:LLY
-
To the contrary, regulation must endeavor to more respectfully, expansively, and creatively accommodate the rational preferences of diverse patients in order to avoid leaving so much opportunity on the table. If we can agree on the need for such personalized regulation, we are more likely to find a way...
-
Each of us must find a way to balance and come to terms with the many conflicting influences that in total serve to catalyze constructive innovation for society, but which can feel disorienting at the level of the individual. Our professional success and personal happiness is presumably determined by...
-
Obama's effort to prioritize time with family has drawn criticism; his ability to prevail here offers a hopeful lesson for workers everywhere. Read More...
-
Digital health aspires to elevate human health and the practice of medicine by enabling providers to offer compassionate care with engaged patients, care that is informed by both updated, evidence-driven guidelines and patient data of almost unimaginable richness and depth. If this vision is to be realized...
Posted to
News
by
Health. Care.
on
Sat, Jan 19 2013
Filed under:
Filed under: EMR, electronic medical records, health, Best Practices, Pharma & Healthcare, Innovation & Science, byline=David Shaywitz, Data Driven, digital health, Al Lewis, MEDICAL TECHNOLOGY, Nassim Taleb, medical innovation
-
Small teams of early-stage drug developers that work sequentially on individual assets could yield improved decision making, freeing the team from concerns about losing their jobs if the project is killed, and increasing their attention to the opportunity cost of continuing their current project versus...
-
Digital health entrepreneurs must understand the importance of workflow, and both the strengths and limitations of existing EMRs. Read More...
-
Drug development success involves a complex mixture of science, politics, and luck. Scientists hope that the process can be helped by improving our basic scientific understanding, while consultants hope to help the process by improving the interpersonal dynamics. Success will requires us to identify...
-
Other industries have mastered customer service; now it's time for medicine. Read More...
-
The latest digital health investment report paints a picture of an industry that's looking a lot like a subcategory of traditional tech. This may be fine for producing the next generation of activitiy monitors, scheduling software, and rating platforms, but falls short of delivering meaningful innovation...
Posted to
News
by
Health. Care.
on
Mon, Jan 7 2013
Filed under:
Filed under: health, Qualcomm, Pharma & Healthcare, Innovation & Science, byline=David Shaywitz, Innovation, Rock Health, venture capital, Tech, digital health, Merck, BCBS, ticker=NASDAQ:ATHN, Startups, West Health, medical innovation, ticker=NYSE:MRK, council capital, aberdare, nea, ticker=NASDAQ:QCOM
-
The absence of digital health companies on the agenda of a major healthcare industry conference points to a significant opportunity for future healthcare entrepreneurs and investors. Read More...
Posted to
News
by
Health. Care.
on
Thu, Jan 3 2013
Filed under:
Filed under: Pharma & Healthcare, Innovation & Science, byline=David Shaywitz, Intelligent Investing, ticker=NYSE:JNJ, ticker=NYSE:PFE, Startups, ticker=NYSE:WLP, ticker=NYSE:AET, ticker=NYSE:MRK
-
My heart is with those who are determined to identify and follow their passion; I am more encouraged by the writer who decides at the age of 40 to become a doctor than by the lawyer who decides to grit out a miserable existence because the pay is good and the responsibilities defined. Read More...
-
A measure of humility is in order. Just as a gene sequence is not a drug, information is not a cure. Getting there will take patience, persistence, money and aligned interests. The most successful innovators in digital health will see the promise of the technology, but also accept, embrace, and ideally...
Posted to
News
by
Health. Care.
on
Sun, Dec 30 2012
Filed under:
Filed under: EMR, electronic medical records, health, Medicine, eHealth, Pharma & Healthcare, byline=David Shaywitz, Innovation, science, mHealth, Data Driven, digital health, genomics, Startups, discovery, human genome project, algorithms
-
It's intellectually foolish and journalistically lazy to reduce complex medical and policy questions to a scorecard of industry affiliations. Read More...
Posted to
News
by
Health. Care.
on
Thu, Dec 27 2012
Filed under:
Filed under: health, Pharma & Healthcare, Innovation & Science, byline=David Shaywitz, Strategies & Solutions, Medical research, biopharmaceutical, conflict of interest, piety, pharmascolds
-
Three tension to watch in 2013: (1) Preventive health vs excessive medicalizations; (2) Standardization of medical practice; (3) Industrialization of drug discovery Read More...
Posted to
News
by
Health. Care.
on
Mon, Dec 24 2012
Filed under:
Filed under: health, Best Practices, Pharma & Healthcare, Innovation & Science, byline=David Shaywitz, Medical research, Drug discovery, Startups, standardization, cheesecake factory, medical innovation, business processes